Literature DB >> 21376832

Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.

Silvia Bolognin1, Luigi Messori, Denise Drago, Chiara Gabbiani, Laura Cendron, Paolo Zatta.   

Abstract

Amyloid-β(1-42) (Aβ) is believed to play a crucial role in the ethiopathogenesis of Alzheimer's Disease (AD). In particular, its interactions with biologically relevant metal ions may lead to the formation of highly neurotoxic complexes. Here we describe the species that are formed upon reacting Aβ with several biometals, namely copper, zinc, iron, and with non-physiological aluminum to assess whether different metal ions are able to differently drive Aβ aggregation. The nature of the resulting Aβ-metal complexes and of the respective aggregates was ascertained through a number of biophysical techniques, including electrospray ionization mass spectrometry, dynamic light scattering, fluorescence, transmission electron microscopy and by the use of conformation-sensitive antibodies (OC, αAPF). Metal binding to Aβ is shown to confer highly different chemical properties to the resulting complexes; accordingly, their overall aggregation behaviour was deeply modified. Both aluminum(III) and iron(III) ions were found to induce peculiar aggregation properties, ultimately leading to the formation of annular protofibrils and of fibrillar oligomers. Notably, only Aβ-aluminum was characterized by the presence of a relevant percentage of aggregates with a mean radius slightly smaller than 30 nm. In contrast, both zinc(II) and copper(II) ions completely prevented the formation of soluble fibrillary aggregates. The biological effects of the various Aβ-metal complexes were studied in neuroblastoma cell cultures: Aβ-aluminum turned out to be the only species capable of triggering amyloid precursor and tau181 protein overproduction. Our results point out that Al can effectively interact with Aβ, forming "structured" aggregates with peculiar biophysical properties which are associated with a high neurotoxicity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376832     DOI: 10.1016/j.biocel.2011.02.009

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  31 in total

Review 1.  Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design.

Authors:  Durga Dharmadana; Nicholas P Reynolds; Charlotte E Conn; Céline Valéry
Journal:  Interface Focus       Date:  2017-06-16       Impact factor: 3.906

Review 2.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

Review 3.  Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.

Authors:  Paul J Derry; Muralidhar L Hegde; George R Jackson; Rakez Kayed; James M Tour; Ah-Lim Tsai; Thomas A Kent
Journal:  Prog Neurobiol       Date:  2019-10-08       Impact factor: 11.685

Review 4.  Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy.

Authors:  Ryan C McCarthy; Daniel J Kosman
Journal:  Cell Mol Life Sci       Date:  2014-10-30       Impact factor: 9.261

Review 5.  Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.

Authors:  Chang Kong; Hao Xie; Zhenxing Gao; Ming Shao; Huan Li; Run Shi; Lili Cai; Shanshan Gao; Taolei Sun; Chaoyang Li
Journal:  Virol Sin       Date:  2019-05-15       Impact factor: 4.327

Review 6.  Neurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer's disease.

Authors:  Mangaldeep Dey; Rakesh Kumar Singh
Journal:  Pharmacol Rep       Date:  2022-01-27       Impact factor: 3.024

7.  Divalent copper ion bound amyloid-β(40) and amyloid-β(42) alloforms are less preferred than divalent zinc ion bound amyloid-β(40) and amyloid-β(42) alloforms.

Authors:  Orkid Coskuner
Journal:  J Biol Inorg Chem       Date:  2016-09-22       Impact factor: 3.358

8.  Resveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Aβ and Aβ-metal complexes toxicity.

Authors:  Alberto Granzotto; Paolo Zatta
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

Review 9.  Importance and management of micronutrient deficiencies in patients with Alzheimer's disease.

Authors:  Bárbara Rita Cardoso; Cristiane Cominetti; Silvia Maria Franciscato Cozzolino
Journal:  Clin Interv Aging       Date:  2013-05-10       Impact factor: 4.458

10.  Copper prevents amyloid-β(1-42) from forming amyloid fibrils under near-physiological conditions in vitro.

Authors:  Matthew Mold; Larissa Ouro-Gnao; Beata M Wieckowski; Christopher Exley
Journal:  Sci Rep       Date:  2013-02-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.